| [1] |
李成荣. 自身炎症性疾病[J]. 中华儿科杂志，2008, 46(11): 842-847.
|
| [2] |
Kelley RI, Takada I. Hereditary periodic fever[J]. N Engl J Med, 2002, 346(18): 1415-1416.
|
| [3] |
沈敏. 自身炎症性疾病和自身免疫病[J]. 中华临床免疫和变态反应杂志，2014, 8(4): 322-328.
|
| [4] |
Better OS, Zemer D. Familial Mediterranean fever[J]. Dtsch Med Wochenschr, 1991, 116(14): 548-552.
|
| [5] |
Ates İ, Akca Ö, Bülbü İ, et al. Case of familial mediterranean fever presenting with constant abdominal pain[J]. Reumatol Clín, 2016, 12(5): 299-300.
|
| [6] |
Mansfield E, Chae JJ, Komarow HD, et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments[J]. Blood, 2001, 98(3): 851-859.
|
| [7] |
Tomiyama N, Higashiuesato Y, Oda T, et al. MEFV mutation analysis of familial Mediterranean fever in Japan[J]. Clin Exp Rheumatol, 2008, 26(1): 13-17.
|
| [8] |
Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1 beta production[J]. Proc Natl Acad Sci USA, 2006, 103(26): 9982-9987.
|
| [9] |
Peces R, Afonso S, Peces C, et al. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report[J]. BMC Med Genet, 2017, 18(1): 97.
|
| [10] |
Barut K, Sahin S, Adrovic A, et al. Familial Mediterranean fever in childhood: a single center experience[J]. Rheumatol Int, 2018, 38(1): 67-74.
|
| [11] |
Heller H, Gafni J, Michaeli D, et al. The arthritis of familial Mediterranean fever (FMF)[J]. Arthritis Rheum, 1966, 9(1): 1-17.
|
| [12] |
Tunca M, Akar S, Onen F et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study[J]. Medicine (Baltimore), 2005, 84(1): 1-11.
|
| [13] |
Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever[J]. Semin Arthritis Rheum, 1996, 26(3): 612-627.
|
| [14] |
Soriano A, Manna R. Familial Mediterranean fever: new phenotypes[J]. Autoimmun Rev, 2012, 12(1): 31-37.
|
| [15] |
Papadopoulos VP, Giaglis S, Mitroulis I, et al. The population genetics of Familial Mediterranean fever: a Meta-analysis study[J]. Ann Hum Genet, 2008, 72(Pt 6): 752-761.
|
| [16] |
Ozalkaya E, Mir S, Sozeri B, et al. Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey[J]. Rheumatol Int, 2011, 31(6): 779-784.
|
| [17] |
Habahbeh L, Hiary MA, Zaben SF, et al. Genetic profile of patients with familial Mediterranean fever (FMF): single center experience at King Hussein Medical Center (KHMC)[J]. Med Arch, 2015, 69(6): 417-420.
|
| [18] |
Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements[J]. Neth J Med, 2007, 65(9): 318-324.
|
| [19] |
Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations[J]. Eur J Hum Genet, 2001, 9(7): 473-483.
|
| [20] |
韩丽芳，蔡军伟，颜亮，等. 中国人群MEFV基因多态性研究[J]. 实用医学杂志，2006, 22(11): 1234-1235.
|
| [21] |
Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever[J]. Autoimmun Rev, 2014, 13(4-5): 388-390.
|
| [22] |
Yalcinkaya F, Ozen S, Ozcakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood[J]. Rheumatology (Oxford), 2009, 48(4): 395-398.
|
| [23] |
Özçakar ZB, Yalçınkaya F, Çakar N, et al. Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF[J]. Eur J Pediatr, 2011, 170(8): 1055-1057.
|
| [24] |
Kondi A, Hentgen V, Piram M, et al. Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders[J]. Rheumatology (Oxford), 2010, 49(11): 2200-2203.
|
| [25] |
Padeh S, Gerstein M, Berkun Y. Colchicine is a safe drug in children with familial Mediterranean fever[J]. J Pediatr, 2012, 161(6): 1142-1146.
|
| [26] |
Cerquaglia C, Diaco M, Nucera G, et al. Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update[J]. Curr Drug Targets Inflamm Allergy, 2005, 4(1): 117-124.
|
| [27] |
Ozkaya N, Yalçinkaya F. Colchicine treatment in children with familial Mediterranean fever[J]. Clin Rheumatol, 2003, 22(4-5): 314-317.
|
| [28] |
Amital H, Ben-Chetrit E. Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to？[J]. Clin Exp Rheumatol, 2004, 22(4 Suppl 34): S4-S7.
|
| [29] |
Grossman C, Farberov I, Feld O, et al. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine[J]. Rheumatol Int, 2019, 39(3): 517-523.
|